Role of D-type cyclins in heart development and disease.
A defining feature of embryonic cardiomyocytes is their relatively high rates of proliferation. A gradual reduction in proliferative capacity throughout development culminates in permanent cell cycle exit by the vast majority of cardiomyocytes around the perinatal period. Accordingly, the adult heart has severely limited capacity for regeneration in response to injury or disease. The D-type cyclins (cyclin D1, D2, and D3) along with their catalytically active partners, the cyclin dependent kinases, are positive cell cycle regulators that play important roles in regulating proliferation of cardiomyocytes during normal heart development. While expression of D-type cyclins is generally low in the adult heart, expression levels are augmented in association with cardiac hypertrophy, but are uncoupled from myocyte cell division. Accordingly, re-activation of D-type cyclin expression in the adult heart has been implicated in pathophysiological processes via mechanisms distinct from those that drive proliferation during cardiac development. Growth factors and other exogenous agents regulate D-type cyclin production and activity in embryonic and adult cardiomyocytes. Understanding differences in the precise intracellular mediators downstream from these signalling molecules in embryonic versus adult cardiomyocytes could prove valuable for designing strategies to reactivate the cell cycle in cardiomyocytes in the setting of cardiovascular disease in the adult heart.
Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.
Adam
A
Hotchkiss
Jessica
J
Robinson
Jessica
J
MacLean
Tiam
T
Feridooni
Karim
K
Wafa
Kishore B S
KB
Pasumarthi
D000818:Animals; D006332:Cardiomegaly / Q000378:metabolism* / Q000473:pathology; D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology; D049109:Cell Proliferation / Q000187:drug effects; D056741:Cyclin D / Q000235:genetics / Q000502:physiology*; D005318:Fetal Heart / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D006321:Heart / Q000187:drug effects / Q000196:embryology* / Q000254:growth & development; D006801:Humans; D035683:MicroRNAs / Q000494:pharmacology; D009203:Myocardial Infarction / Q000378:metabolism* / Q000473:pathology; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D038081:Organogenesis / Q000187:drug effects / Q000502:physiology*
D056741:Cyclin D; D035683:MicroRNAs